Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 12—December 2021
Dispatch

Rift Valley Fever Virus Seroprevalence among Humans, Northern KwaZulu-Natal Province, South Africa, 2018–2019

Janusz T. PawęskaComments to Author , Veerle Msimang, Joe Kgaladi, Orienka Hellferscee, Jacqueline Weyer, and Petrus Jansen van Vuren
Author affiliations: National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa (J.T. Pawęska, V. Msimang, J. Kgaladi, O. Hellferscee, J. Weyer, P. Jansen van Vuren); University of Pretoria, Pretoria, South Africa (J.T. Pawęska, J. Weyer); Rand Water, Vereeniging, South Africa (J. Kgaladi); Australian Centre for Disease Preparedness, CSIRO-Health and Biosecurity, Geelong, Victoria, Australia (P. Jansen van Vuren)

Main Article

Figure

Distribution of human Rift Valley fever virus seropositivity and ward-specific seropositivity in northern municipalities of the uMkhanyakude District, KwaZulu-Natal Province, South Africa, April 2018–August 2019. Inset shows location of uMkhanyakude District (red box) in South Africa. Map was constructed in ArcGIS 10.2 (Esri, https://www.esri.com) using district, municipal, and ward boundaries, facilities, and participants’ residential coordinates collected during the study. Data are available under CC-BY 4.0 (Creative Commons Attribution, https://creativecommons.org) license.

Figure. Distribution of human Rift Valley fever virus seropositivity and ward-specific seropositivity in northern municipalities of the uMkhanyakude District, KwaZulu-Natal Province, South Africa, April 2018–August 2019. Inset shows location of uMkhanyakude District (red box) in South Africa. Map was constructed in ArcGIS 10.2 (Esri, https://www.esri.com) using district, municipal, and ward boundaries, facilities, and participants’ residential coordinates collected during the study. Data are available under CC-BY 4.0 (Creative Commons Attribution, https://creativecommons.org) license.

Main Article

Page created: October 06, 2021
Page updated: November 19, 2021
Page reviewed: November 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external